Business Context and Reporting Period
Company: Omeros Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: November 7, 2013
Reporting Period: The filing announces financial results for the three and nine months ended September 30, 2013.
Key Financial Metrics
The provided text is a cover sheet for a Form 8-K and does not contain specific financial data. It references a press release (Exhibit 99.1) for details on revenue, profit, cash flow, margins, debt, and liquidity. Consequently, the filing text does not provide a clear value for any specific financial metric.
Material Changes
The filing text does not disclose specific material changes versus prior periods. It serves only to notify investors that results for the three and nine months ended September 30, 2013, have been issued.
Guidance, Outlook, and Risks
The text contains no management commentary, guidance, outlook, or specific risk factors. It includes a standard disclaimer stating that the information in this Current Report and its exhibit shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into other SEC filings.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 7, 2013) for actual revenue, net loss, and cash position figures.
- Verify the specific clinical trial progress or regulatory updates mentioned in the referenced press release, as the 8-K text itself lacks these details.
- Confirm the company's cash runway and burn rate from the full financial statements referenced in the exhibit.